PFBT
ADMA icon

Parkside Financial Bank & Trust’s ADMA Biologics ADMA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.77K Buy
529
+242
+84% +$3.82K ﹤0.01% 1840
2025
Q4 		$5.24K Buy
287
+165
+135% +$2.78K ﹤0.01% 1786
2025
Q3 		$1.79K Sell
122
-23
-16% -$394 ﹤0.01% 2066
2025
Q2 		$2.64K Buy
145
+20
+16% +$408 ﹤0.01% 1902
2025
Q1 		$2.48K Buy
125
+86
+221% +$1.49K ﹤0.01% 1824
2024
Q4 		$669 Buy
39
+9
+30% +$169 ﹤0.01% 1807
2024
Q3 		$600 Buy
+30
New +$467 ﹤0.01% 1798

Other funds holding ADMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Parkside Financial Bank & Trust's ADMA Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its ADMA Biologics (ADMA) stake by 84% in Q1 2026, buying an estimated $3.82K and bringing the position to 529 shares worth $4.77K. The position accounts for ﹤0.01% of the portfolio, ranked #1840.

Parkside Financial Bank & Trust first reported a position in ADMA in Q3 2024 and has held it in 7 quarters since. The position peaked at $5.24K in Q4 2025. 356 funds tracked by Wall St. Rank hold ADMA as of Q1 2026.

  • Parkside Financial Bank & Trust held 529 shares of ADMA Biologics worth $4.77K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 242 ADMA Biologics shares in Q1 2026, an estimated $3.82K.
  • ADMA Biologics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1840 holding.
  • Parkside Financial Bank & Trust first reported a position in ADMA Biologics in Q3 2024 and has held it in 7 quarters since.
  • Parkside Financial Bank & Trust's ADMA Biologics position peaked at $5.24K in Q4 2025.
  • 356 funds tracked by Wall St. Rank held ADMA Biologics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.